The future of autism treatments is increasingly growing more optimistic. Biotechnology companies have seen a shift in focus from merely treating the symptoms that result from autism to more diligent research attacking the core issues in an attempt to hopefully one day eradicate the disease.
BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read at the bottom of / About Us / Section Add this page to your favorite Social Bookmarking websites
HOUSTON, TX--Emerging Healthcare Solutions, Inc. (Pink Sheets: EHSI) announced that the Company has just executed an option with Stand-By Systems, owner of the FDA approved SBS 1615 catalytic oxygen generator and other FDA approved breakthrough emergency portable oxygen systems and devices.
BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read at the bottom of / About Us / Section Add this page to your favorite Social Bookmarking websites
The future of autism treatments is increasingly growing more optimistic. Biotechnology companies have seen a shift in focus from merely treating the symptoms that result from autism to more diligent research attacking the core issues in an attempt to hopefully one day eradicate the disease. 
